Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for Neurogene (NGNE) over the last 2 years, with Dec 2024 value amounting to $17.6 million.

  • Neurogene's Shares Outstanding (Diluted Average) rose 24.86% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year increase of 24.86%. This contributed to the annual value of $17.6 million for FY2024, which is 277.22% up from last year.
  • As of FY2024, Neurogene's Shares Outstanding (Diluted Average) stood at $17.6 million, which was up 277.22% from $4.7 million recorded in FY2023.
  • Neurogene's 5-year Shares Outstanding (Diluted Average) high stood at $17.6 million for FY2024, and its period low was $4.7 million during FY2023.
  • Its 2-year average for Shares Outstanding (Diluted Average) is $11.1 million, with a median of $11.1 million in 2023.
  • Data for Neurogene's Shares Outstanding (Diluted Average) shows a peak YoY spiked of 277.22% (in 2024) over the last 5 years.
  • Over the past 2 years, Neurogene's Shares Outstanding (Diluted Average) (Yearly) stood at $4.7 million in 2023, then surged by 277.22% to $17.6 million in 2024.